No full-text available
To read the full-text of this research,
you can request a copy directly from the authors.
Virtual monochromatic spectral imaging for the evaluation of vertebral inconspicuous osteoblastic metastases from lung
Abstract
Background
The diagnosis of inconspicuous osteoblastic metastases (OBMs) is a challenge in computed tomography (CT) images. The virtual monochromatic spectral (VMS) image of spectral CT is useful for the detection of the low-contrast lesions.
Purpose
To select the optimal monochromatic level for VMS images of spectral CT for detecting and diagnosing inconspicuous OBMs of the vertebra from lung cancer.
Material and Methods
Thirty-five patients underwent spectral CT for chest or abdomen. The CT number and standard deviation (SD) of lesions and adjacent normal bone and the SD value of subcutaneous fat were measured on the conventional polychromatic image (140 kVp) and 40–140 keV VMS images. The contrast-to-noise ratio (CNR) was compared among the 11 VMS images and 140 kVp images. The scores of two observers for different images and the inter-observer agreement were evaluated. The diameter and CNR of the detected and missed lesions were assessed.
Results
The lowest image noise was distributed in 70 and 140 keV images and the highest CNR was noted in 70 keV images. Good and moderate inter-observer agreement were identified for the evaluation of diagnostic ability, and the subjective scores of two observers for 60 and 70 keV images were increased compared with 140 kVp images ( P < 0.05). The diameter had no significant difference between the detected and missed lesions. The CNR of the missed lesions was reduced compared with detected lesions.
Conclusion
VMS images at 70 keV may be optimal for detecting and diagnosing inconspicuous OBMs from lung cancer.
... Yue et al. (14) used VMI for the detection of inconspicuous osteoblastic metastases of the vertebra from lung cancer. They suggested that VMI at 70 keV could be the best for diagnosing inconspicuous vertebral metastases, which have a similar density and are therefore not distinguishable from normal vertebrae ( Fig. 3) (14). ...
... Yue et al. (14) used VMI for the detection of inconspicuous osteoblastic metastases of the vertebra from lung cancer. They suggested that VMI at 70 keV could be the best for diagnosing inconspicuous vertebral metastases, which have a similar density and are therefore not distinguishable from normal vertebrae ( Fig. 3) (14). ...
Computed tomography (CT) is an important imaging modality in evaluating thoracic malignancies. The clinical utility of dual-energy spectral computed tomography (DESCT) has recently been realized. DESCT allows for virtual monoenergetic or monochromatic imaging, virtual non-contrast or unenhanced imaging, iodine concentration measurement, and effective atomic number (Zeff map). The application of information gained using this technique in the field of thoracic oncology is important, and therefore many studies have been conducted to explore the use of DESCT in the evaluation and management of thoracic malignancies. Here we summarize and review recent DESCT studies on clinical applications related to thoracic oncology.
... Yue et al. used postprocessing, and specifically VMI, to improve the detection of subtle osteoblastic metastases of the vertebra from lung neoplasm. The authors demonstrated that VMI 70 keV could be the best tool for diagnosing not clearly evident vertebral metastases, which may have a density very similar to neighboring bone tissue [108]. A recent review [109] showed that VNC images have been used for detecting bone marrow oedema in vertebral fractures, and could increase lesion attenuation. ...
Dual-energy computed tomography (DECT) is one of the most promising technological innovations made in the field of imaging in recent years. Thanks to its ability to provide quantitative and reproducible data, and to improve radiologists' confidence, especially in the less experienced, its applications are increasing in number and variety. In thoracic diseases, DECT is able to provide well-known benefits, although many recent articles have sought to investigate new perspectives. This narrative review aims to provide the reader with an overview of the applications and advantages of DECT in thoracic diseases, focusing on the most recent innovations. The research process was conducted on the databases of Pubmed and Cochrane. The article is organized according to the anatomical district: the review will focus on pleural, lung parenchymal, breast, mediastinal, lymph nodes, vascular and skeletal applications of DECT. In conclusion, considering the new potential applications and the evidence reported in the latest papers, DECT is progressively entering the daily practice of radiologists, and by reading this simple narrative review, every radiologist will know the state of the art of DECT in thoracic diseases.
The latest evolutions in Computed Tomography (CT) technology have several applications in oncological imaging. The innovations in hardware and software allow for the optimization of the oncological protocol. Low-kV acquisitions are possible thanks to the new powerful tubes. Iterative reconstruction algorithms and artificial intelligence are helpful for the management of image noise during image reconstruction. Functional information is provided by spectral CT (dual-energy and photon counting CT) and perfusion CT.
In recent years, dual-energy computed tomography (DECT) is increasingly used in routine clinical practice due to technical developments. DECT can provide both material-nonspecific and material-specific energy-dependent information like virtual monoenergetic or monochromatic imaging (VMI), virtual non-contrast or unenhanced imaging (VNC), iodine concentration (IC) measurements, and the effective atomic number (Zeff). In thoracic oncology, these applications might have additional benefits, in the diagnostic and therapy response evaluation of lung cancer, especially in the context with new treatments based on antiangiogenetic agents and tyrosine kinase inhibitors. However, besides the problem that DECT parameter values are not uniform across studies, the DECT technique also has some general limitations. First, the use of DECT is limited in obese patients because of high image noise often interfering with structural and functional image analysis. Second, larger image datasets require increased data storage capabilities and appropriate adjustment of clinical workflows.Photon-counting detector computed tomography (PCDCT) is an emerging technology, using energy-resolving X-ray detectors that differ substantially from conventional energy-integrating detectors. The results of initial studies indicate its potentially high impact on lung imaging by correcting for artifacts, having an excellent spatial resolution, reducing radiation exposure, and optimizing the use of contrast agents. However, till a broad use in clinical routines, further research is necessary.
Background:
Central lung cancer with obstructive atelectasis is very common in clinical practice. Determination of the tumor borderline is important. Conventional computed tomography (CT) alone may not be sufficiently accurate to distinguish central lung cancer from obstructive atelectasis. Spectral CT can improve the soft-tissue resolution greatly. In this study, we evaluated the application value of double-layer spectral detector CT in differentiating central lung cancer from atelectasis.
Methods:
A total of 51 patients (37 males) with pathologically confirmed central lung cancer accompanied by atelectasis were enrolled. The rates of differentiation between tumors and atelectasis were retrospectively analyzed using conventional CT and three types of spectral images (40 keV virtual monoenergetic imaging, iodine density map, and their fusion image) of unenhanced scans as well as arterial and venous phases. Cochran's Q test and Friedman test were used to compare the differentiation rates and the maximal diameters of the tumors in each image.
Results:
Among the 51 cases, conventional CT, 40 keV monoenergetic, iodine density, and their fusion images of the venous phase were successful in differentiating tumors from atelectasis in 17 (33.33%), 35 (68.63%), 39 (76.47%), and 38 (74.51%) cases, respectively. The differentiation rates of the 40 keV monoenergetic, iodine density, and fusion images were significantly higher than those of conventional images (χ2=-0.35, -0.43, and -0.41, respectively, all P<0.001). There were no significant differences in the differentiation rates among the 40 keV monoenergetic, iodine density, and fusion images (χ2=-0.06, -0.08, 0.02, respectively, all P=1.00). The maximal tumor diameters in the four images did not significantly differ (χ2=3.61, P=0.31). Conventional and spectral images of unenhanced and arterial phases could not/barely identify the tumor borderlines.
Conclusions:
Venous-phase spectral images of double-layer spectral detector CT can differentiate most central lung cancers from atelectasis, and the maximal diameter measurement of the tumor is reliable. Double-layer spectral detector CT can accurately identify the borderlines of most central lung cancers through spectral images during routine CT examinations without requiring other imaging modalities. Therefore, this method has considerable clinical value for applications in tumor staging, efficacy evaluation, and radiotherapy.
With increasing incidence and mortality, cancer is the leading cause of death in China and is a major public health problem. Because of China's massive population (1.37 billion), previous national incidence and mortality estimates have been limited to small samples of the population using data from the 1990s or based on a specific year. With high-quality data from an additional number of population-based registries now available through the National Central Cancer Registry of China, the authors analyzed data from 72 local, population-based cancer registries (2009-2011), representing 6.5% of the population, to estimate the number of new cases and cancer deaths for 2015. Data from 22 registries were used for trend analyses (2000-2011). The results indicated that an estimated 4292,000 new cancer cases and 2814,000 cancer deaths would occur in China in 2015, with lung cancer being the most common incident cancer and the leading cause of cancer death. Stomach, esophageal, and liver cancers were also commonly diagnosed and were identified as leading causes of cancer death. Residents of rural areas had significantly higher age-standardized (Segi population) incidence and mortality rates for all cancers combined than urban residents (213.6 per 100,000 vs 191.5 per 100,000 for incidence; 149.0 per 100,000 vs 109.5 per 100,000 for mortality, respectively). For all cancers combined, the incidence rates were stable during 2000 through 2011 for males (+0.2% per year; P = .1), whereas they increased significantly (+2.2% per year; P < .05) among females. In contrast, the mortality rates since 2006 have decreased significantly for both males (−1.4% per year; P < .05) and females (−1.1% per year; P < .05). Many of the estimated cancer cases and deaths can be prevented through reducing the prevalence of risk factors, while increasing the effectiveness of clinical care delivery, particularly for those living in rural areas and in disadvantaged populations. CA Cancer J Clin 2016.
The purpose of this study was to evaluate image quality and status of lymph nodes in laryngeal and hypopharyngeal squamous cell carcinoma (SCC) patients using spectral CT imaging.
Thirty-eight patients with laryngeal and hypopharyngeal SCCs were scanned with spectral CT mode in venous phase. The conventional 140-kVp polychromatic images and one hundred and one sets of monochromatic images were generated ranging from 40 keV to 140 keV. The mean optimal keV was calculated on the monochromatic images. The image quality of the mean optimal keV monochromatic images and polychromatic images was compared with two different methods including a quantitative analysis method and a qualitative analysis method. The HU curve slope (λHU) in the target lymph nodes and the primary lesion was calculated respectively. The ratio of λHU was studied between metastatic and non-metastatic lymph nodes group.
A total of 38 primary lesions were included. The mean optimal keV was obtained at 55±1.77 keV on the monochromatic images. The image quality evaluated by two different methods including a quantitative analysis method and a qualitative analysis method was obviously increased on monochromatic images than polychromatic images (p<0.05). The ratio of λHU between metastatic and non-metastatic lymph nodes was significantly different in the venous phase images (p<0.05).
The monochromatic images obtained with spectral CT can be used to improve the image quality of laryngeal and hypopharyngeal SCC and the N-staging accuracy. The quantitative ratio of λHU may be helpful for differentiating between metastatic and non-metastatic cervical lymph nodes.
Bone metastases occur frequently in patients with advanced cancer and are a serious complication of cancer. The decision to treat is often individualized, based on each patient's clinical presentation, life expectancy, and quality of life.
We reviewed the current literature pertaining to management of metastatic disease to bone, and the medical, radiotherapeutic, and surgical treatment options for management of bone metastasis are discussed.
Current management of skeletal metastasis includes analgesia, systemic therapy, radiation therapy, and surgery. We propose treatment algorithms for management of vertebral and nonvertebral bone metastases and suggest individualized interventions based on clinical presentation.
Management of bone metastases is complex and requires a multidisciplinary approach. The goal of treatment is often palliative, and intervention and treatment regimens should be individualized based on the specific clinical presentation of each patient.
This study measured observers' ability to detect and locate focal lesions on simulated CT images. The difficulty of the detection task was manipulated by changing the difference in attenuation between the lesion and its background (contrast), the random variation in the CT values (noise) or the lesion's size. The human observers' performance was compared to that of matched filter detector, modified to include the effects introduced by the display window and the uncertainty about the lesion's location on the image. Changes in lesion contrast, lesion size and noise produced large variations in both the lesion signal-to-noise ratio (a measure of the matched filter detector's performance) and estimated measures of the observer's detection and localization ability. Changes in observers' performance were closely related to changes in lesion signal-to-noise ratio. Generally, changes in lesion contrast, lesion size or noise that produced similar values of lesion signal-to-noise ratios had equivalent effects upon the observers' performance.
Purpose:
To assess the feasibility of virtual nonenhanced (VNE) images derived from single-source fast kVp-switching dual-energy CT, namely material suppressed iodine (MSI) images in evaluating gastric tumors, and to calculate potential radiation dose reductions for a dual-phase gemstone spectral imaging (GSI) abdominal CT compared with a standard triple-phase protocol.
Materials and methods:
The institutional review board approved this prospective study; all patients provided written informed consent. 95 patients underwent preoperative enhanced CT that included true nonenhanced (TNE) with conventional 120 kVp mode, arterial phase (AP) and venous phase (VP) with GSI mode. MSI images were obtained from enhanced images of AP. Two abdominal radiologists independently evaluated the image quality of TNE and MSI images using a 5-point scale. Interobserver agreement was accessed by kappa value. The sensitivity for lesions on TNE and MSI images were evaluated. The CT number of various regions and image noise was measured on TNE and MSI images. The relative enhancement CT value of lesions, contrast to noise(CNR) of gastric tumors and effective radiation doses for triple-phase and dual-phase protocol were calculated. Differences were tested for statistical significance using Wilcoxon signed rank test and paired t-test.
Results:
Interobserver agreement about image quality was excellent(all kappa>0.750). No significant difference in image quality was found between TNE 4.32 ± 0.53 and MSI 4.21±0.51 images (P>0.05). In respect to the sensitivities for gastric tumors, lymph node and liver metastasis, there were no significant differences between TNE and MSI images (all P>0.05). The CT number on TNE and MSI images, respectively, for gastric tumor were 32.79HU ± 6.45 and 35.02HU ± 5.01 (P=0.006); lymph nodes, 31.33HU ± 6.37 and 31.61HU ± 5.73 (P=0.334); liver metastasis, 37.79HU ± 8.40 and 39.76HU ± 8.50 (P=0.041); liver, 56.56HU ± 7.87 and 58.32HU ± 8.73 (P=0.057); psoas muscle, 52.30HU ± 5.63 and 51.80HU±6.86 (P=0.533); aorta, 38.16HU ± 4.91 and 42.49HU ± 4.49 (P<0.001). The CT relative enhancement value of gastric tumors, lymph node and liver metastasis had no significant difference between TNE and MSI images (P=0.083, 0.194, 0.156). MSI images had higher image noise than TNE images (P<0.001). The CNR of gastric tumor on MSI images was higher than that on TNE images (P<0.001). The effective dose for triple-phase was 25.1mSv±6.2 and that for dual-phase was 17.7mSv ± 4.1. The dose saving by removing the TNE was 7.5 mSv (30.5%).
Conclusion:
In patients with gastric tumors, the MSI images derived from single-source fast kVp-switching dual-energy CT can provide comparable image quality to TNE images and reliable diagnostic information; replacing TNE images will lower radiation dose by 30.5%.
Objectives:
To evaluate the diagnostic efficacy of spectral CT for the differentiation of osteoblastic metastases (OBMs) from bone islands (BIs) in patients with lung cancer.
Methods:
In 94 patients with lung cancer who underwent spectral CT, focal hyperdense lesions in vertebral bodies were diagnosed as OBMs or BIs. Regions of interest were placed within each lesion to measure the mean CT value and its standard deviation (SD) on polychromatic single-energy CT (SECT) at 140 kVp and dual-energy virtual monochromatic spectral (VMS) images. The mean bone (Dbone(wa)) and water densities (Dwa(bone)) of each lesion were also measured. The slope (k) of the spectral curve was calculated. Independent-sample t-test was used to compare those values between OBMs and BIs. Receiver operator characteristic analysis was performed to compare the area under curve (AUC) for the differentiation of OBMs from BIs.
Results:
A total of 79 OBMs and 43 BIs were confirmed. The CT and SD values on SECT at 140 kVp and VMS images at 50-130 keV, k value, and Dbone(wa) for OBMs were significantly lower than for BIs; Dwa(bone) was significantly higher for OBMs than for BIs (p<0.05 for all). The AUC for the SD value at 110 keV was the highest among those parameters. The optimal cut-off value for this differentiation was 68.6 HU for the SD value on VMS images at 110 keV with sensitivity of 93.0% and specificity of 93.3%.
Conclusion:
Spectral CT is helpful for the differentiation of OBMs from BIs in patients with lung cancer, particularly using SD of the CT value on high-energy VMS images.
Rationale and objectives:
To evaluate the diagnostic accuracy, image quality, and radiation dose of prospective electrocardiogram (ECG)-triggered high-pitch dual-source computed tomography (DSCT) in infants and young children with complex coarctation of the aorta (CoA).
Materials and methods:
Forty pediatric patients aged < 4 years with suspected CoA underwent prospective ECG-triggered high-pitch DSCT angiography and transthoracic echocardiography (TTE). Surgery and/or conventional cardiac angiography (CCA) were performed in all patients. The diagnostic accuracy of DSCT angiography and TTE was compared to the surgical and/or CCA findings. The causes of misdiagnosis and miss were analyzed, and the advantages and limitation of both imaging modalities were evaluated. Image quality of DSCT was evaluated, and effective radiation dose was calculated.
Results:
The sensitivity, specificity, positive predictive value, negative predictive value, and overall diagnostic accuracy of DSCT in evaluation of complex CoA were 92.37%, 98.51%, 97.32%, 93.57%, and 96.25%, respectively. There was a significant difference in the accuracy between DSCT and TTE (χ² = 9.9, P＜.05). For a total of 80 extracardiac anomalies, the sensitivity (98.8%, 79/80) of DSCT was greater than that of TTE (62.5%; 50 of 80). On the contrary, for 38 cardiac anomalies, the sensitivity (78.9%, 30 of 38) of DSCT was lesser than that of TTE (100%; 38 of 38). The mean score of image quality was 4.27 ± 0.73. The mean effective radiation dose was 0.20 ± 0.09 mSv.
Conclusions:
Prospective ECG-triggered high-pitch DSCT may be a clinical feasible modality in the evaluation of pediatric patients with complex CoA, providing adequate image quality, high diagnostic accuracy, and low radiation dose.
Purpose
To assess the reliability of dual-energy CT (DECT) spectral imaging for the differentiation of bone metastases (BMs) from Schmorl's nodes (SNs) in the vertebrae of cancer patients.
Materials and Methods
In this retrospective study, 102 cancer patients who underwent DECT (GE spectral CT Discovery CT750 HD scanner) had 110 low density vertebral lesions. Each lesion were characterized as a BM or SN, based on the typical MRI or SPECT/PET-CT findings as well as size and number change in the 6 months follow-up. The means of 140kVp polychromatic CT values, 40-140 keV monochromatic CT values, slopes (k) of the spectral curves, bone(water) and water(bone) densities of BMs and SNs were measured and compared with independent-samples t-test. The difference values of the two lesions and their respective normal bone tissue were calculated (normal density - lesion density) and compared using independent-samples t-test. ROC curves were used to compare the diagnostic efficacies of these measures in the identification of SNs and BMs.
Results
110 lesions consisting of 69 BMs and 41 SNs were identified. The spectral curve patterns and slopes for BMs and SNs were different (p <0.05). The water(bone) density of BMs (1009.02 ± 59.25 mg/cm3) was higher than that of SNs (892.00 ± 83.65 mg/cm3) (p <0.01) while the bone(water) density (43.57 ± 50.87 mg/cm3) was lower than that of SNs (174.60 ± 94.61 mg/cm3) (p <0.01). The 40 keV CT value, k, bone(water) density and water(bone) density had a higher diagnostic efficacy for differentiating the two lesions than polychromatic CT value (p <0.05).
Conclusions
Dual-energy CT imaging is accurate enough for identification of osteolytic metastases and Schmorl's nodes.
Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths expected in the United States in the current year and compiles the most recent data on cancer incidence, mortality, and survival based on incidence data from the National Cancer Institute, the Centers for Disease Control and Prevention, and the North American Association of Central Cancer Registries and mortality data from the National Center for Health Statistics. A total of 1,660,290 new cancer cases and 580,350 cancer deaths are projected to occur in the United States in 2013. During the most recent 5 years for which there are data (2005-2009), delay-adjusted cancer incidence rates declined slightly in men (by 0.6% per year) and were stable in women, while cancer death rates decreased by 1.8% per year in men and by 1.5% per year in women. Overall, cancer death rates have declined 20% from their peak in 1991 (215.1 per 100,000 population) to 2009 (173.1 per 100,000 population). Death rates continue to decline for all 4 major cancer sites (lung, colorectum, breast, and prostate). Over the past 10 years of data (2000-2009), the largest annual declines in death rates were for chronic myeloid leukemia (8.4%), cancers of the stomach (3.1%) and colorectum (3.0%), and non-Hodgkin lymphoma (3.0%). The reduction in overall cancer death rates since 1990 in men and 1991 in women translates to the avoidance of approximately 1.18 million deaths from cancer, with 152,900 of these deaths averted in 2009 alone. Further progress can be accelerated by applying existing cancer control knowledge across all segments of the population, with an emphasis on those groups in the lowest socioeconomic bracket and other underserved populations. CA Cancer J Clin 2013;. © 2013 American Cancer Society.
Objectives:
To investigate the value of CT spectral imaging in differentiating hepatocellular carcinoma (HCC) from focal nodular hyperplasia (FNH) during the arterial phase (AP) and portal venous phase (PP).
Methods:
Fifty-eight patients with 42 HCCs and 16 FNHs underwent spectral CT during AP and PP. The lesion-liver contrast-to-noise ratio (CNR) at different energy levels, normalised iodine concentrations (NIC) and the lesion-normal parenchyma iodine concentration ratio (LNR) were calculated. The two-sample t test compared quantitative parameters. Two readers qualitatively assessed lesion types according to imaging features. Sensitivity and specificity of the qualitative and quantitative studies were compared.
Results:
In general, CNRs at low energy levels (40-70 keV) were higher than those at high energy levels (80-140 keV). NICs and LNRs for HCC differed significantly from those of FNH: mean NICs were 0.25 mg/mL ± 0.08 versus 0.42 mg/mL ± 0.12 in AP and 0.52 mg/mL ± 0.14 versus 0.86 mg/mL ± 0.18 in PP. Mean LNRs were 2.97 ± 0.50 versus 6.15 ± 0.62 in AP and 0.99 ± 0.12 versus 1.22 ± 0.26 in PP. NICs and LNRs for HCC were lower than those of FNH. LNR in AP had the highest sensitivity and specificity in differentiating HCC from FNH.
Conclusions:
CT spectral imaging may help to increase detectability of lesions and accuracy of differentiating HCC from FNH.
Key points:
• CT spectral imaging may help to detect hepatocellular carcinoma (HCC). • CT spectral imaging may help differentiate HCC from focal nodular hyperplasia. • Quantitative analysis of iodine concentration provides greater diagnostic confidence. • Treatment can be given with greater confidence.
Purpose:
To investigate the performance of spectral CT in the depiction of the gastrocolic ligament (GCL) compared to conventional polychromatic CT.
Methods:
Gemstone spectral CT and conventionally polychromatic CT examinations were randomly allocated to be performed on 62 consecutive patients. A total of 11 groups of monochromatic images were generated on energy levels ranging from 40 to 140 keV at an interval of 10 keV. A five-score classification system was used to evaluate the performances of CT images in the demonstration of GCL. The inter-observer agreement between two radiologists in their evaluation of the GCL by each method was evaluated using kappa statistics.
Results:
There were statistically significant differences between the spectral CT and polychromatic CT in their abilities to highlight the GCL (observer 1: χ(2) = 18.310, P < 0.001; observer 2: χ(2) = 19.780, P < 0.001). The distinct display (score ≥ 3) rates of the GCL by integrated monochromatic images were higher than that of polychromatic images (P < 0.001). The best energy level for displaying the GCL by spectral CT was 50-70 keV. The kappa value for the image scores on the integrated keV images between the two radiologists was higher than that for polychromatic CT images (P < 0.01).
Conclusions:
Spectral CT can improve the visualisation of the GCL compared to polychromatic CT.
To assess image quality and diagnostic accuracy of monochromatic imaging from spectral CT in patients with small HCC (≤3 cm).
Twenty-seven patients with 31 HCC underwent spectral CT to generate conventional 140-kVp polychromatic images (group A) and monochromatic images with energy levels from 40 to 140 keV (group B) during the late arterial phase (LAP) and the portal venous phase (PVP). Two-sample t tests compared the tumour-to-liver contrast-to-noise ratio (CNR) and mean image noise. Lesion detection for LAP, reader confidence and readers' subjective evaluations of image quality were recorded.
Highest CNRs in group B were distributed at 40, 50 and 70 keV. Higher CNR values and lesion conspicuity scores (LCS) were obtained in group B than in group A (CNR 3.36 ± 2.07 vs. 1.47 ± 0.89 in LAP; 2.29 ± 2.26 vs. 1.58 ± 1.75 in PVP; LCS 2.82, 2.84, 2.63 and 2.53 at 40-70 keV, respectively, vs. 1.95) (P < 0.001). Lowest image noise for group B was at 70 keV, resulting in higher image quality than that in group A (4.70 vs. 4.07; P < 0.001).
Monochromatic energy levels of 40-70 keV can increase detectability in small HCC and this increase might not result in image quality degradation. KEY POINTS : • Spectral computed tomography may help the detection of small hepatocellular carcinoma. • Monochromatic energy levels of 40-70 keV increase the sensitivity for detection. • Prospective study showed that monochromatic imaging provides greater diagnostic confidence. • Monochromatic energy level of 70 keV improves the overall image quality.
To compare image quality and radiation dose using Adaptive Statistical Iterative Reconstruction (ASiR) and Filtered Back Projection (FBP) in patients weighing ≥ 91 kg.
In this Institution Review Board-approved retrospective study, single-phase contrast-enhanced abdominopelvic CT examinations of 100 adults weighing ≥ 91 kg (mean body weight: 107.6 ± 17.4 kg range: 91-181.9 kg) with (1) ASiR and (2) FBP were reviewed by two readers in a blinded fashion for subjective measures of image quality (using a subjective standardized numerical scale and objective noise) and for radiation exposure. Imaging parameters and radiation dose results of the two techniques were compared within weight and BMI sub-categories.
All examinations were found to be of adequate quality. Both subjective (mean = 1.4 ± 0.5 vs. 1.6 ± 0.6, P < 0.05) and objective noise (13.0 ± 3.2 vs.19.5 ± 5.7, P < 0.0001) were lower with ASiR. Average radiation dose reduction of 31.5 % was achieved using ASiR (mean CTDIvol. ASiR: 13.5 ± 7.3 mGy; FBP: 19.7 ± 9.0 mGy, P < 0.0001). Other measures of image quality were comparable between the two techniques. Trends for all parameters were similar in patients across weight and BMI sub-categories.
In obese individuals, abdominal CT images reconstructed using ASiR provide diagnostic images with reduced image noise at lower radiation dose.
• CT images in obese adults are noisy, even with high radiation dose. • Newer iterative reconstruction techniques have theoretical advantages in obese patients. • Adaptive statistical iterative reconstruction should reduce image noise and radiation dose. • This has been proven in abdominopelvic CT images of obese patients.
The purpose of this study was to select the optimal monochromatic level for virtual monochromatic spectral (VMS) imaging to minimize the image noise of the liver parenchyma and to acquire a high contrast-to-noise ratio (CNR) of hypovascular hepatic metastases in the portal-dominant phase.
This study was conducted with the approval of our institutional review board, and written informed consent was obtained from all the participating patients. Ninety patients with hepatic metastases were scanned by fast kilovoltage switching dual-energy computed tomography in the portal-dominant phase. One hundred one sets of VMS images in the range of 40 to 140 keV at 1-keV intervals were reconstructed. The image noise of the liver parenchyma in each patient and the CNR of each metastasis (n = 303) were measured on all the 101 VMS image sets. Data were analyzed by the paired t test and mixed-effects model. Bonferroni's method was used for multiple comparisons.
The lowest noise of the liver parenchyma was obtained in 6, 15, 31, 29, 7, 1, and 1 patient at 67, 68, 69, 70, 71, 72, and 73 keV, respectively. The mean noise of the liver parenchyma on the 69-keV VMS images in all 90 patients was significantly lower than that on the 67-, 68-, 71-, 72-, and 73-keV VMS images (P < 0.001); however, there was no significant difference in the mean noise of the liver parenchyma between the 69-keV and 70-keV VMS images (P = 0.279). For 95% of the hepatic metastases (288/303 metastases), the highest metastasis-to-liver CNR was obtained in the 66- to 71- keV VMS images. The mean metastasis-to-liver CNR for the 303 metastases was numerically highest at 68 keV; however, there was no significant difference in the mean metastasis-to-liver CNR between the 68-keV and 69-keV images (P = 0.737) or between the 68-keV and 70-keV images (P = 0.103).
VMS imaging at approximately 70 keV (69-70 keV) yielded the lowest image noise of the liver parenchyma and a high CNR for hypovascular hepatic metastases in the portal-dominant phase.
The purpose of this study was to select the optimal monochromatic level for gemstone spectral imaging (GSI) to minimize both the image noise and beam-hardening artifacts (BHAs) in nonenhanced cranial computed tomography (CT).
One hundred subjects scanned with GSI mode on Discovery CT750HD were enrolled. Six sets of CT images were obtained from a single GSI acquisition: conventional 140 kilovolt (peak) (kV[p]) polychromatic images and 5 sets of monochromatic images (80, 75, 70, 65, and 60 kiloelectron volts [keV]). The background noise in the corona and the BHA in 4 different anatomic regions (medulla oblongata, cerebellar, pons, and the inferior part of frontal lobes) were measured and compared between the polychromatic and monochromatic images. Beam-hardening artifact is defined as the square root of the squared noise difference between the region of interest and background.
The background noise with the monochromatic sets reduced by -36%, -11%, 11%, 10%, and -14%, respectively, compared to the polychromatic image. For BHA, the reductions were 73%, 91%, 92%, and 80%; 53%, 75%, 65%, and 41.%; 27%, 59%, 44%, and 26%; 7%, 46%, 25%, and 20%; and -14%, 33%, 6%, and 19% for the 4 regions of interest. Both the 70 and 65 keV sets had positive background noise reduction (P = 0.285) and BHA reduction with 70 keV were statistically higher (P < 0.05).
In the nonenhanced cranial CT with GSI, the optimal monochromatic level was determined at 70 keV to provide both image noise reduction (11%) and BHA reduction compared to the conventional polychromatic images.
To compare image quality obtained in phantoms with virtual monochromatic spectral (VMS) imaging with that obtained with conventional 120-kVp computed tomography (CT) for a given radiation dose.
Three syringes were filled with a diluted contrast medium (each syringe contained a contrast medium with a different iodine concentration [5, 10, or 15 mg of iodine per milliliter]), and a fourth syringe was filled with water. These syringes were placed in a torso phantom meant to simulate the standard human physique. The phantom was examined with a CT system and use of the fast kilovoltage switching (80 and 140 kVp) and conventional (120 kVp) modes. Image noise and contrast-to-noise (CNR) ratio were analyzed on VMS images and 120-kVp CT images.
Image noise on VMS images in the range of 67-72 keV was significantly lower than that on the 120-kVp CT images (P < .014). Image noise was lowest at 69 keV and was 12% lower when compared with that on 120-kVp CT images. CNR on the VMS images was highest at 68 keV. CNR on the VMS images obtained at 68 keV in the syringes filled with diluted contrast material (5, 10, and 15 mg of iodine per milliliter) was 28%, 31%, and 30% higher, respectively, compared with that on the 120-kVp CT images (P < .001).
VMS imaging at approximately 70 keV yielded lower image noise and higher CNR than did 120-kVp CT for a given radiation dose. VMS imaging has the potential to replace 120-kVp CT as the standard CT imaging modality, since optimal VMS imaging may be expected to yield improved image quality in a patient with standard body habitus.
The skeleton is one of the most frequent sites for metastases from non-small cell lung cancer (NSCLC), and skeletal-related events (SREs) can decrease quality of life (QOL). However, limited guidance exists regarding the diagnosis and treatment of bone metastases in patients with NSCLC.
Data on the burden of skeletal morbidity and the diagnosis and treatment of bone metastases in patients with NSCLC were obtained from reviewing the published literature (PubMed) and presentations and abstracts from recent oncology congresses.
Bone metastases are common but underdiagnosed in patients with NSCLC. Most NSCLC patients with bone metastases develop > or =1 SRE during their lifetimes. As survival improves with new treatment modalities, the prevalence of SREs is likely to increase. Direct costs of SREs and their subsequent supportive care are approximately $28,000 per patient. Although bone metastases often are not diagnosed until after the onset of symptoms, early treatment can delay the onset of potentially debilitating SREs. In patients with NSCLC and other solid tumors (n=773), zoledronic acid (ZOL; 4 mg via 15-min infusion every 3 weeks) delayed the median time to first on-study SRE by >80 days compared with placebo (p=0.009). Moreover, ZOL significantly reduced the ongoing risk of SREs by 32% versus placebo (p=0.016).
Skeletal morbidity is an important concern in patients with NSCLC. The incidence of SREs is expected to increase as survival improves in this setting. Prevention of SREs with therapies such as ZOL may preserve patients' QOL and possibly reduce healthcare costs.
To retrospectively evaluate lesion findings at computed tomography (CT) performed as part of a combined positron emission tomography (PET)/CT examination in patients suspected of having metastatic bone lesions-lesions that were detected with fluorine 18 fluorodeoxyglucose (FDG) PET as part of the same examination-and to correlate the CT and FDG PET findings.
This HIPAA-compliant study had institutional review board approval, and the need for patient informed consent was waived. Three hundred fifty-nine consecutive patients (191 male patients, 168 female patients; mean age, 56.9 years; age range, 8-92 years) underwent PET/CT. PET images were first reviewed by nuclear medicine physicians who had no clinical information regarding the presence or absence of bone metastasis by using a five-point grading system (0, a lesion was definitely negative for metastasis; 1, a lesion was probably negative; 2, a lesion was equivocal; 3, a lesion was probably positive; and 4, a lesion was definitely positive). For lesions assigned a grade of 3 or 4 at PET, CT characteristics such as the presence or absence of morphologic changes or accompanying findings (including bone destruction) were assessed by radiologists on the CT images obtained during the same imaging session.
One hundred seventy-nine lesions in 55 patients were considered to be probable or definite bone metastases at PET. One hundred thirty-three of these lesions in 33 patients were clinically confirmed to be bone metastases at follow-up and/or histopathologic examination. CT revealed osteolytic changes in 41 (31%) and osteoblastic changes in 21 (16%) of the 133 lesions, but no or nonspecific changes were seen at CT in 49 (37%) and 22 lesions (17%), respectively. Of the 179 lesions suspected at PET, 46 ultimately proved to be nonosseous or false-positive for bone metastasis. Of these 46 lesions, 38 were not located in the bone but in adjacent tissues such as the pleura.
CT images obtained as part of PET/CT scanning were useful in yielding the precise location of bone lesions and thus helping avoid misdiagnosis of bone metastasis; however, CT revealed morphologic changes in only half of the lesions assigned a grade of 3 or 4 at PET.
The results for 37 surgical interventions in 31 consecutive patients with non-small cell lung cancer (NSCLC) with symptomatic spinal cord compression were reviewed retrospectively.
To evaluate postoperative outcomes and survival rates of NSCLC patients surgically treated for symptomatic spinal metastasis.
For patients with spinal cord compression secondary to lung cancer, the prognosis is usually poor. However, with the development of new chemotherapeutic drugs and targeted therapeutic agents, the survival rate may be better.
From November 2000 to March 2005, 31 patients with symptomatic metastatic spinal cord compression secondary to NSCLC underwent palliative surgery using a posterolateral transpedicular approach (PTA) or combined posterior and anterior procedures. The indication for surgery was neurologic progression due to spinal cord compression.
The patients ranged in age from 20 to 81 years (mean, 61.4 years). Twenty-eight patients (90%) underwent PTA, and 3 patients had combined posterior and anterior procedures. Neurologic improvement by at least one Frankel grade was noted in 25 of 31 cases (80%). Overall, 74% of patients (23 of 31) were able to walk after surgery. There was no case of intraoperative mortality, but two deaths occurred in the postoperative period. Median survival time was 8.8 months.
Even though lung cancer is considered an aggressive tumor, it is justifiable to aggressively treat patients with symptomatic spinal cord compression. Surgery by PTA can lead to good results in these patients.
High-definition CT gemstone spectral imaging of the brain: Initial results of selecting optimal monochromatic image for beam-hardening artifacts and image noise reduction
- X Z Lin
- F Miao
- Li
- High
Cancer statistics, 2013